AMPH logo

Amphastar Pharmaceuticals (AMPH) Shareholders Equity

Annual Shareholders Equity

$639.42 M
+$110.76 M+20.95%

31 December 2023

AMPH Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$727.68 M
+$14.33 M+2.01%

30 September 2024

AMPH Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AMPH Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.9%+22.3%
3 y3 years+58.9%+69.2%
5 y5 years+92.3%+86.9%

AMPH Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+58.9%at high+69.2%
5 y5 yearsat high+92.3%at high+92.8%
alltimeall timeat high+173.9%at high+189.3%

Amphastar Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$727.68 M(+2.0%)
June 2024
-
$713.35 M(+6.1%)
Mar 2024
-
$672.36 M(+5.2%)
Dec 2023
$639.42 M(+21.0%)
$639.42 M(+7.4%)
Sept 2023
-
$595.14 M(+1.0%)
June 2023
-
$589.24 M(+7.4%)
Mar 2023
-
$548.58 M(+3.8%)
Dec 2022
$528.66 M(+18.7%)
$528.66 M(+4.7%)
Sept 2022
-
$505.17 M(+1.2%)
June 2022
-
$499.31 M(+4.1%)
Mar 2022
-
$479.52 M(+7.6%)
Dec 2021
$445.52 M(+10.7%)
$445.52 M(+3.6%)
Sept 2021
-
$430.18 M(+1.9%)
June 2021
-
$421.99 M(+4.1%)
Mar 2021
-
$405.56 M(+0.8%)
Dec 2020
$402.31 M(+5.5%)
$402.31 M(-0.7%)
Sept 2020
-
$405.23 M(+1.9%)
June 2020
-
$397.68 M(+5.3%)
Mar 2020
-
$377.51 M(-1.0%)
Dec 2019
$381.37 M
$381.37 M(-2.1%)
Sept 2019
-
$389.40 M(+0.4%)
June 2019
-
$387.85 M(+15.8%)
DateAnnualQuarterly
Mar 2019
-
$334.99 M(+0.8%)
Dec 2018
$332.44 M(-0.4%)
$332.44 M(+4.1%)
Sept 2018
-
$319.42 M(-0.3%)
June 2018
-
$320.53 M(-2.0%)
Mar 2018
-
$327.10 M(-2.0%)
Dec 2017
$333.74 M(+1.4%)
$333.74 M(+0.9%)
Sept 2017
-
$330.65 M(-0.8%)
June 2017
-
$333.31 M(+2.4%)
Mar 2017
-
$325.56 M(-1.1%)
Dec 2016
$329.25 M(+11.4%)
$329.25 M(+0.2%)
Sept 2016
-
$328.45 M(+6.8%)
June 2016
-
$307.46 M(+3.7%)
Mar 2016
-
$296.58 M(+0.4%)
Dec 2015
$295.51 M(+4.8%)
$295.51 M(+4.1%)
Sept 2015
-
$283.79 M(-0.5%)
June 2015
-
$285.26 M(+2.1%)
Mar 2015
-
$279.28 M(-0.9%)
Dec 2014
$281.86 M(+12.1%)
$281.86 M(-0.4%)
Sept 2014
-
$283.12 M(-1.6%)
June 2014
-
$287.74 M(+14.4%)
Mar 2014
-
$251.54 M(-0.0%)
Dec 2013
$251.54 M(+7.8%)
$251.54 M
Dec 2012
$233.44 M
-

FAQ

  • What is Amphastar Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Amphastar Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Amphastar Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of AMPH is $639.42 M

What is the all time high annual shareholders equity for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high annual stockholders equity is $639.42 M

What is Amphastar Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, AMPH annual stockholders equity has changed by +$110.76 M (+20.95%)

What is Amphastar Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of AMPH is $727.68 M

What is the all time high quarterly shareholders equity for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high quarterly stockholders equity is $727.68 M

What is Amphastar Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, AMPH quarterly stockholders equity has changed by +$132.54 M (+22.27%)